Mice and men make livers differently

May 21, 2007 Mice and men make livers differently

An MIT research team studying gene regulation in mouse and human liver cells has found that master regulatory proteins function differently in the two. From left, post-doc Robin Dowell, Professor Ernest Fraenkel, graduate student Kenzie MacIsaac and research technician William Gordon discuss their research. Photo / Donna Coveney

Scientists often study mice as a model for human biology and disease, because their basic biological processes are assumed to be essentially the same as those of humans.

But now, a team of MIT researchers has uncovered a surprising difference. In a study of gene regulation in mouse and human liver cells, they found that master regulatory proteins function in very different ways in mice and humans.

"Evolution has discovered several different ways to make a liver from the same building blocks," said Ernest Fraenkel, MIT assistant professor of biological engineering and leader of the research team. "Comparing these different ways of regulating genes may unlock some of nature's most closely guarded secrets."

The work, which will be published in the May 21 online edition of Nature Genetics, could help identify patterns in the extremely complicated control mechanisms involved in gene expression.

"You can think of it as two different dialects of the same language. By exploring the human and mouse versions, we hope to find an underlying grammar," said Fraenkel.

Every cell in the human (or mouse) body has the same collection of genes, but the genome of each cell is carefully regulated so that only certain genes are expressed. Regulatory proteins known as transcription factors control this expression by binding to specific locations within the genome and turning nearby genes on or off.

The researchers and their colleagues had previously worked out many aspects of gene regulation in the human liver, which is one reason the researchers chose to study the liver. In the current study they compared 4,000 human genes with nearly identical counterparts, known as homologous genes, from mouse liver cells.

Given the similarity between the two species' DNA sequences, the researchers expected that transcription factors would bind to the same sites in most pairs of homologous genes. To their surprise, they found that most of the binding sites--between 41 percent and 89 percent, depending on the transcription factor--were in different locations in humans and mice.

"The number of genes with the identical regulation in both species was very, very small," Fraenkel said.

Before they began, the researchers expected to see some differences in gene regulation between mice and humans, because the human liver has evolved to process cooked food, said Fraenkel. However, the magnitude of change was much higher than they anticipated.

Fraenkel speculated that the changes accumulated without having much of an effect on gene expression. Unless the location of binding sites affects gene expression, it is not under any natural selection pressure.

All of that meaningless variation makes it harder to identify the small number of genes where binding site migrations do have an evolutionary impact, because they are being drowned out by all the insignificant changes, Fraenkel said. In future studies, the research team plans to investigate why some genes' binding sites are conserved over time while others shift.

"We want to understand what's special about those genes," Fraenkel said.
Fraenkel said the results should provide guidance for researchers who study mice to better understand human biology. "To get the most out of mice for biomedical research we need to fully map out the regulation in both organisms," he said.

Lead authors on the paper are Duncan Odom, a former postdoctoral associate at the Whitehead Institute for Biomedical Research now at Cancer Research UK, and Robin Dowell, a postdoctoral fellow in MIT's Computer Science and Artificial Intelligence Laboratory.

Other authors are Elizabeth Jacobsen and Caitlin Conboy, technical assistants at the Whitehead Institute; William Gordon, a technical assistant in the Department of Biological Engineering; Timothy Danford, Kenzie MacIsaac and Alexander Rolfe, graduate students in electrical engineering and computer science; and David Gifford, professor of electrical engineering and computer science.

Source: MIT


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 5 /5 (1 vote)


May 21, 2007 all stories

Comments: 0

5 /5 (1 vote)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories




  • hide
  • Relevant PhysicsForums posts

  • Chest x-ray???
    created Nov 27, 2009
  • Multiple Sclerosis & CCSVI
    created Nov 26, 2009
  • 23 Years in a Vegetative State....or not?
    created Nov 25, 2009
  • Has the H1N1 vaccine been scientifically proven to work?
    created Nov 24, 2009
  • More from Physics Forums - Medical Sciences

Other News

Understanding the pros and cons of health overhaul (AP)

Understanding the pros and cons of health overhaul

Medicine & Health / Health

created 14 hours ago | popularity 5 / 5 (1) | comments 0

(AP) -- Maybe you've been reading the health care bill in your spare time. Then perhaps you can answer this question:


Hajj devil stoning ritual biggest swine flu risk (AP)

Hajj devil stoning ritual biggest swine flu risk

Medicine & Health / Diseases

created 13 hours ago | popularity 1 / 5 (1) | comments 0

(AP) -- Millions of Muslim pilgrims, many wearing surgical masks, jostled together shoulder-to-shoulder furiously casting pebbles at stone walls representing the devil Saturday - the hajj ritual of highest ...


smoking, cigarette

Vaccine being developed to help smokers quit

Medicine & Health / Medications

created Nov 20, 2009 | popularity 4.3 / 5 (15) | comments 10

(PhysOrg.com) -- Glaxo-SmithKline has joined forces with Nabi Pharmaceuticals to produce a vaccine to help smokers give up their addiction permanently.


Implant-based cancer vaccine is first to eliminate tumors in mice

Implant-based cancer vaccine is first to eliminate tumors in mice

Medicine & Health / Cancer

created Nov 25, 2009 | popularity 4.7 / 5 (23) | comments 7

(PhysOrg.com) -- A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week in the journal ...


Drug users know their stuff

Drug users know their stuff

Medicine & Health / Psychology & Psychiatry

created Nov 24, 2009 | popularity 5 / 5 (8) | comments 5

Drug users are well informed about the harms associated with the drugs they use, and perceive alcohol and tobacco to be amongst the most dangerous substances, according to a survey by UCL (University College ...